1. Home
  2. TWIN vs TRDA Comparison

TWIN vs TRDA Comparison

Compare TWIN & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TWIN
  • TRDA
  • Stock Information
  • Founded
  • TWIN 1918
  • TRDA 2016
  • Country
  • TWIN United States
  • TRDA United States
  • Employees
  • TWIN N/A
  • TRDA N/A
  • Industry
  • TWIN Industrial Machinery/Components
  • TRDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • TWIN Industrials
  • TRDA Health Care
  • Exchange
  • TWIN Nasdaq
  • TRDA Nasdaq
  • Market Cap
  • TWIN 186.2M
  • TRDA 222.5M
  • IPO Year
  • TWIN N/A
  • TRDA 2021
  • Fundamental
  • Price
  • TWIN $14.99
  • TRDA $5.92
  • Analyst Decision
  • TWIN Strong Buy
  • TRDA Strong Buy
  • Analyst Count
  • TWIN 1
  • TRDA 3
  • Target Price
  • TWIN $12.00
  • TRDA $25.67
  • AVG Volume (30 Days)
  • TWIN 34.7K
  • TRDA 350.3K
  • Earning Date
  • TWIN 11-05-2025
  • TRDA 11-04-2025
  • Dividend Yield
  • TWIN 1.12%
  • TRDA N/A
  • EPS Growth
  • TWIN N/A
  • TRDA N/A
  • EPS
  • TWIN N/A
  • TRDA N/A
  • Revenue
  • TWIN $340,738,000.00
  • TRDA $79,476,000.00
  • Revenue This Year
  • TWIN $10.79
  • TRDA N/A
  • Revenue Next Year
  • TWIN $8.43
  • TRDA N/A
  • P/E Ratio
  • TWIN N/A
  • TRDA N/A
  • Revenue Growth
  • TWIN 15.46
  • TRDA N/A
  • 52 Week Low
  • TWIN $6.16
  • TRDA $4.93
  • 52 Week High
  • TWIN $15.00
  • TRDA $21.79
  • Technical
  • Relative Strength Index (RSI)
  • TWIN 66.28
  • TRDA 50.74
  • Support Level
  • TWIN $14.11
  • TRDA $5.82
  • Resistance Level
  • TWIN $15.00
  • TRDA $6.90
  • Average True Range (ATR)
  • TWIN 0.67
  • TRDA 0.36
  • MACD
  • TWIN -0.03
  • TRDA 0.03
  • Stochastic Oscillator
  • TWIN 97.05
  • TRDA 38.95

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: